RADIESSE® 1.5ml

Where can I buy this product?

RADIESSE® 1.5ml is available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license. First-time buyers can register an online account by providing required professional information, including medical license verification and a valid shipping address. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support. We are committed to ensuring all products are sourced and sold exclusively to qualified professionals.

Product Information

What is RADIESSE® 1.5ml?

RADIESSE® 1.5ml is a sterile, injectable, subdermal implant manufactured by Merz Aesthetics. Its unique composition consists of synthetic Calcium Hydroxylapatite (CaHA) microspheres (approximately 30%) suspended in an aqueous carboxymethylcellulose gel carrier (approximately 70%). This formulation is designed for soft tissue augmentation, providing both immediate volume and long-term biostimulation.

RADIESSE® is intended for injection into the deep dermis or subdermis to correct moderate to severe facial wrinkles and folds, restore facial volume (e.g., cheeks, temples, jawline), and for correcting volume loss in the dorsum of the hands. It is important to note that Radiesse® is a CaHA-based filler and is NOT reversible with hyaluronidase.

Storage: Store according to manufacturer guidelines, typically at controlled room temperature between 15°C and 25°C (59°F and 77°F). Do not freeze. Protect from light.

Authenticity: Health Supplies Plus guarantees that all RADIESSE® products sourced are authentic from the manufacturer or authorized distributors.

Note: For professional use only by trained and licensed practitioners experienced in the use of CaHA fillers and deep injection techniques, in accordance with local medical device regulations.

How does RADIESSE® 1.5ml work? (Based on Manufacturer Information)

RADIESSE® provides a dual mechanism of action:

1. Immediate Volumization: Upon injection, the gel carrier provides immediate volume and lift, instantly correcting wrinkles, folds, or contour deficiencies.
2. Neocollagenesis (Collagen Stimulation): Over weeks and months, the CaHA microspheres act as a scaffold, stimulating fibroblasts to produce new Type I and Type III collagen. As the gel carrier is gradually absorbed, this newly formed collagen matrix provides durable, natural-looking structural support and volume.

This biostimulatory effect leads to sustained improvement in skin quality and volume beyond the initial filling effect of the gel carrier. RADIESSE® is known for its high viscosity and elasticity (G’), providing excellent lift capacity and support for structural contouring.

Treatment results are immediately visible due to the gel carrier, with ongoing improvement as collagen is produced. The manufacturer suggests a duration of effect often lasting 12 to 18 months, or even longer in some individuals, depending on patient factors, treatment area, and volume injected. Radiesse® is also available in formulations containing 0.3% lidocaine (Radiesse® (+)) for enhanced patient comfort; this specific product listing refers to the formulation which may or may not contain lidocaine based on regional availability (always check product details).

Indications for Use (Common Applications)

Based on its properties and common clinical use internationally, RADIESSE® 1.5ml is typically indicated for adults for:

• Correction of moderate to severe facial wrinkles and folds (e.g., nasolabial folds, marionette lines).
• Facial volume restoration and contouring (e.g., cheeks, temples, pre-jowl sulcus, chin, jawline).
• Correction of volume loss in the dorsum of the hands.
• Addressing facial lipoatrophy in appropriate patient populations.

It requires deep dermal or subcutaneous injection techniques. Appropriate patient selection, thorough anatomical knowledge, and consideration of contraindications outlined in the product literature are crucial.

Primary Benefits (Based on Manufacturer Claims & Clinical Use)

• Provides immediate volume correction and long-term collagen stimulation.
• High viscosity and elasticity offer excellent lift and structural support.
• Versatile for treating deep wrinkles, folds, and facial/hand volume loss.
• Durable results, often lasting 12-18 months or more.
• Biocompatible CaHA microspheres are gradually metabolized.
• Well-established product with extensive clinical history.

Side Effects and Safety Information

Practitioners must obtain and consult the complete product information provided by the manufacturer for comprehensive details on administration, contraindications, warnings, precautions, and potential adverse events before using this product. Discussing all potential risks and side effects with patients is essential, including its non-reversible nature with hyaluronidase. Advanced training in deep injection techniques and thorough anatomical knowledge are mandatory for safe use.

Common side effects expected with CaHA filler injections include temporary, injection-site related reactions:

• Swelling (can be significant initially)
• Bruising
• Redness
• Tenderness or Pain
• Itching
• Firmness or Palpable Lumps/Bumps (CaHA nodules may be more challenging to manage than HA)
• Ecchymosis
• Erythema

Severe Adverse Events:
Injecting deep, structural fillers carries significant risks. Practitioners must be prepared to manage serious complications. Potential severe adverse events include:

• Vascular Occlusion (VO): Accidental injection into a blood vessel can obstruct blood flow, potentially leading to severe tissue necrosis (tissue death), scarring, or (in rare cases involving facial arteries) blindness or stroke. As Radiesse is not reversible with hyaluronidase, prevention through meticulous technique and appropriate VO management protocols (excluding hyaluronidase as a primary solvent for the CaHA component) are even more critical.
• Severe allergic reactions or hypersensitivity
• Inflammation, infection, or abscess formation
• Nodule or granuloma formation (CaHA nodules may require different management strategies than HA nodules, e.g., intralesional steroids, surgical excision in refractory cases).
• Migration of microspheres (rare)
• Prolonged pain or numbness
• Herpetic eruptions (cold sores) in susceptible individuals
• Needle jamming (rare, can be related to product viscosity/handling)

Any signs of vascular compromise, infection, hypersensitivity, or persistent adverse reactions require immediate medical evaluation and management according to established best practices.